|
HS Code |
938996 |
| Species | Bifidobacterium juvenis |
| Type | Probiotic bacterium |
| Gram Stain | Gram-positive |
| Shape | Rod-shaped |
| Oxygen Requirement | Anaerobic |
| Common Use | Gut microbiome health |
| Origin | Human gastrointestinal tract |
| Storage Temperature | 2-8°C (refrigerated) |
| Recommended Dosage | 1-10 billion CFU daily |
| Format | Capsule or powder |
| Shelf Life | 12-24 months |
| Ph Resistance | Survives gastric acidity |
| Allergen Free | Yes (in most commercial products) |
| Clinical Research | Limited human studies |
| Potential Benefits | Digestive health and immune support |
As an accredited Bifidobacterium Juvenis factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle with blue label, containing 60 capsules of **Bifidobacterium Juvenis** (10 billion CFU each), securely sealed. |
| Shipping | Bifidobacterium juvenis is shipped in temperature-controlled packaging to maintain viability. The product is sealed in airtight containers, protected from moisture, heat, and light. Expedited shipping options are available to ensure prompt delivery. Shipping includes tracking and handling instructions to ensure product integrity through transit and upon arrival. |
| Storage | **Bifidobacterium juvenis** should be stored in a cool, dry place, ideally at temperatures below 8°C (refrigerated) to maintain viability. Keep the container tightly sealed and protected from light, moisture, and heat. Avoid repeated freeze-thaw cycles. For long-term storage, freezing at -20°C or lower is recommended. Always follow manufacturer guidelines for specific storage requirements and expiration dates. |
| Purity 99%: Bifidobacterium Juvenis with 99% purity is used in infant formula fortification, where it enhances gut microbiota balance and supports immune health.Colony Forming Units 1x10¹⁰ CFU/g: Bifidobacterium Juvenis at 1x10¹⁰ CFU/g is used in dietary supplements, where it improves digestive system regulation and promotes regular bowel movements.Moisture Content <5%: Bifidobacterium Juvenis with less than 5% moisture content is used in powder blends for probiotics, where it ensures superior shelf stability and maintains microbial viability.Encapsulated Formulation: Bifidobacterium Juvenis in an encapsulated formulation is used in functional beverage production, where it provides high survival rates during gastric transit.Stability at 25°C: Bifidobacterium Juvenis stable at 25°C is used in non-refrigerated probiotic capsules, where it guarantees product efficacy throughout retail distribution.Thermal Tolerance up to 45°C: Bifidobacterium Juvenis with thermal tolerance up to 45°C is used in bakery applications, where it retains probiotic activity during moderate heat processing.Particle Size <50 µm: Bifidobacterium Juvenis with particle size less than 50 µm is used in cosmetic formulations, where it facilitates better absorption and even product dispersion.Acid Resistance (pH 2.5): Bifidobacterium Juvenis resistant to pH 2.5 is used in gastrointestinal-targeted tablets, where it survives acidic stomach conditions for maximal intestinal delivery.Lyophilized State: Bifidobacterium Juvenis in a lyophilized state is used in sachets for on-the-go health products, where it prolongs storage life and easy reconstitution.Non-GMO Certified: Bifidobacterium Juvenis classified as non-GMO is used in organic food preparations, where it meets regulatory compliance and consumer demand for natural ingredients. |
Competitive Bifidobacterium Juvenis prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturers like us who have invested decades in active bacterial culture technology watch the conversation around probiotics change year after year. With Bifidobacterium Juvenis, practical science comes together with real-world need. People feel the fatigue and digestive complaints of a busy modern lifestyle, see the constant warnings about antibiotic misuse, and look for genuine help in daily supplements. Where headlines and packaging language tend toward hype, Bifidobacterium Juvenis earns trust through repeated, measured results. Our team doesn’t settle for broad claims. Everything starts with the specific strain, its proven history, and everyday application.
Bifidobacterium Juvenis arose from an early initiative on pediatric gut health. We sourced our founding isolates through institutional partnerships, steering clear of wild fermentation and uncontrolled sourcing, instead focusing on reproducibility. As the manufacturer, every batch runs through an aseptic downstream process, without relying on ambient or batch-to-batch microbial drift. Our staff documents every stage from culture propagation to freeze-drying, so sourcing managers and end-users never wonder about quality diversion. That type of close handling sets this product apart from third-party relabeling—a detail that matters to us not only from a compliance angle but makes a direct difference to the end consumer.
We selected a model, BY-671, that balances thermal stability with a metabolic profile tuned for prebiotic conversion. Many firms opt for higher-yield starter strains, chasing quick titer increases in the reactor, but that sometimes trades off stability once the powder gets into a finished product. This BY-671 model emerged from side-by-side testing in simulated gastric conditions. Every production round uses a patented cryoprotectant mix, holding at least 109 CFU per gram at packaging. Staff technicians take repeated samples along the line, checking not just CFU, but also oxygen sensitivity and acid tolerance, to ensure the strain’s traits appear in the commercial powder—not just in a laboratory seed batch.
Where some products mention “probiotics” in vague terms, our technical staff stands behind measurable specs for Bifidobacterium Juvenis. Each production lot comes with the latest sequence typing confirmation. Incompatibilities from misidentified strains can ripple through a food or supplement line, causing both compliance trouble and irregular performance. With us, what’s on the label always matches what enters the fermenter. We focus on water activity between 0.10-0.15 for shelf-life extension, and invest in foil-aluminum packaging for light, moisture, and oxygen protection throughout transport and storage.
We watch industry trends not from the viewpoint of marketing but by monitoring our batches sent into yogurts, baby formulas, chewable tablets, and newer nutraceutical blends. Some of the earliest results in pediatric formulas caught our attention for more than intellectual curiosity—they resonated with product developers needing a live strain able to survive real-world processing and distribution, not just laboratory simulation. Feedback from pharmaceutical partners trying Bifidobacterium Juvenis in gut health capsules reveals similar points: active titer after tablet compression, maintenance through variable humidity in global shipping, and compatibility with common filler excipients.
Industry-wide, we observe that many suppliers rely on academic references not tied to the exact strain in their blend. We pursue our own battery of tests, constantly re-upping challenge assays against acid, bile, and dry storage stress. This provides our customers fewer surprises when running Bifidobacterium Juvenis blends side by side with current competitors. In some capsule products, our strain outperforms others by surviving GI-mimic conditions into the colon, with over 70 percent of viable cells recovered after acid challenge (based on in-house tests). These data points don’t get flagged as “for lab use only”; they have shown repeatedly to align with clinical outcomes, as customers regularly report consistent positive shifts in stool quality, abdominal comfort, and general wellbeing in surveys and follow-ups.
We see Bifidobacterium Juvenis being integrated from infant formulas to meal replacement shakes for active seniors. In children’s health, the focus lands on balancing microbiota early in life. The BY-671 strain’s docile carbohydrate metabolism reduces gas formation, which parents and clinicians appreciate as it doesn’t bring the same side effects sometimes noted with aggressive lactic acid producers. In formulations aimed at adults, the same traits help maintain regularity without causing sudden bowel changes, which users notice and expect, particularly if they are adjusting medications, traveling, or facing dietary restrictions. The elderly segment needs gentle, resilient organisms, which can withstand both gut pH drift and co-administration with supplements or medications. Our sustained cell counts and documented identity support those specialized uses.
Probiotic buyers often see grand claims and persuasive branding, but we look further. We pay attention to safety certifications, absence of pathogens, and heavy metal clearance, all verified with our own QA team in a controlled plant. Bifidobacterium Juvenis BY-671’s compliance data gets revisited every year with both internal and third-party audits. We invest in traceability for every shipment—customers can request certificate numbers, see batch-specific sequencing, and trust what arrives at their dock. That’s an edge that doesn’t come from mere rebranding of bulk powders. Authenticity protects users, helps regulatory peace of mind, and encourages repeat business from strict clients in clinical and medical nutrition markets.
Our team works hands-on with formulators aiming to include Bifidobacterium Juvenis in a new wave of functional foods and beverages. Adding probiotics to anything that isn’t strictly refrigerated can derail active counts, which is why we suggest pilot production with on-the-spot viability testing. School beverage trials brought up the need for a strain that stands up to low pH juice bases without rapid die-off. Powdered shakes put pressure on both flavor masking and substrate compatibility. With our production system, Bifidobacterium Juvenis resists flavor taint (doesn’t release sharp fermentation byproducts or off-aromas) and disperses evenly in aqueous solutions. R&D staff here hold sessions with customers' teams to adjust prebiotic fiber or protein addition levels, learning together which combinations fit end-user needs and lifestyles. We often send shelf-life samples, sharing full micro reports before, during, and after production scale-up.
Bifidobacterium isn’t a new name, but strain-level differences shape how products perform outside a lab. For years, generic bifidobacterium blends found in bulk have included high-acid producers that lose stability above 25°C, or strains lacking full genetic documentation. We approach every client brief by comparing documented abilities. With BY-671, data shows stable survival in finished forms ranging from fortified milk powders to chocolate coatings—outliving traditional L. acidophilus blends in comparative studies under variable temperature storage. Where some “multispecies” blends struggle with internal competition, our mono-strain BY-671 fills only its own metabolic niche, avoiding the antagonism that can lower effective titers in finished capsules or sachets.
Producing for global food and pharmaceutical markets means meeting strict safety standards. Bifidobacterium Juvenis, as handled here, meets requirements for absence of antibiotic resistance genes, toxin-producing genes, and pathogenic relatives. Every batch traverses PCR screens, and we retain backup samples for traceability. Factory teams calibrate instruments every cycle, logging deviations, and our response protocol launches at the faintest sign of contamination. This attention helps us avoid the product recalls and batch losses seen with less stringent facilities even in developed markets. By investing heavily upstream—starting with pure cultures and detailed environmental sweeps—we send out a product that carries our reputation each time it leaves the plant.
No probiotic pays off for the end user if potency crumbles before ingestion. We learned early that real-world storage—pantries, warehouses, unrefrigerated shelves—stress the powder harder than lab testing alone. Bifidobacterium Juvenis comes pre-formulated for inclusion in shelf-stable blends, owing to careful matrix design and water reduction at final drying. Foil pouching and gas flushing further shield cell viability, and we promote this knowledge to product designers so expensive stocks aren’t wasted through slow attrition before consumption. Our own in-house studies show acceptable viability even after six months in suboptimal conditions, meaning end-of-life product mirrors the specification on delivery day.
We chose to make every stage transparent. Over the years, process engineers reported the usual trouble areas: persistent biofilm, line fouling, variable freeze-dryer cycles, and cold chain interruptions. We adapted by installing continuous environmental monitoring, switching to closed-system fermenters, and training line staff to act on early deviation alerts. Regular audits push us to outpace GMP and HACCP targets. Our department heads meet every quarter to compare field performance data (not just lab reports) with findings from customer complaints and QA tickets, closing gaps with continuous improvement loops. Such feedback, gathered straight from downstream users, helps dial in every new run and prevents drift as the scale increases or the regulatory bar rises.
In the early years, less attention shone on environmental impacts of bioprocessing. Today, we review waste minimization in every production run, recover water from the concentration step, and source energy from renewable distributors whenever possible. The packaging update last year, pushing for lighter and more recyclable materials, has cut our waste by measurable amounts, helping food companies using Bifidobacterium Juvenis reduce their own footprint. We keep pushing upstream partners to certify clean production of packaging film and reagents and examine how every change impacts the downstream environment. It’s a cycle—safer, more stable probiotics mean less spoilage and waste in retail and user hands, and that reality steers our decisions far more than broad ESG buzzwords.
Some marketplace chatter claims all probiotics offer the same value. From our end, that doesn’t reflect what product developers, clinicians, or patients experience. Odd flavors, inconsistent results, or surprise acid spikes always trace back to strain-level differences, uncontrolled blending, or poor quality assurance. Bifidobacterium Juvenis stands apart by maintaining consistent growth rates, balanced fermentation, and genomic clarity that can be demonstrated batch after batch. As the team producing, packaging, and certifying the powder, we’ve heard success stories from long-term pediatric use, improved digestive health in adults facing stress and travel, and stable inclusion in complex multivitamin blends. These aren’t just marketing—they come from batch traceability and ongoing real-world vigilance. Pushing beyond promotional language, our plant team stakes their reputation on continued live-cell delivery for each order, as simple as that.
We work not just to sell lots, but to help design future-forward products, whether the target is the clinical nutrition sector or general wellness market. Since Bifidobacterium Juvenis tolerates a diverse ingredient landscape, our R&D experts routinely consult with end-users on excipient choice, dosing, tableting pressure, and encapsulation dynamics. The partnership doesn’t stop at order fulfillment. We bring back customer insights on taste, mouthfeel, and mixability into our fermentation adjustments, packaging upgrades, and even logistics. Product managers often visit our plant, reviewing real batch runs and sharing ideas for tailored blends. These collaborations create more reliable, appealing offerings—the type that build repeat purchases and strong word of mouth.
Science doesn’t pause, and neither do we. Our pipeline includes new derivative strains building on Bifidobacterium Juvenis’ base, aiming for unique dietary benefits, enhanced stress resilience, or even targeted microbiota modulation in challenging populations. Internal teams monitor not just shelf data but emerging literature, regulatory shifts, and end-user requests. Upgrades sometimes mean tougher process challenges, unexpected micro-interactions, or supply chain hurdles. Still, our company commits to continuous training, rapid integration of new standards, and a willingness to adjust processes at every level. Our aim remains simple: more robust, user-ready live cultures, proven to work beyond the confines of controlled trials, delivering genuine value across the world.
For us, Bifidobacterium Juvenis means more than a catalog entry. It represents years of steady engineering, process discipline, team accountability, and trust earned through traceable results. In an industry fraught with overstatement and under-delivery, we stand by our product as the result of diligence—never just hype, always grounded in manufacturing reality and open communication. Whether your product line includes a first foray into functional foods, or an advanced medical supplement, Bifidobacterium Juvenis offers something many claim but few deliver: true strain focus, proven survival, and reliability in real-world use. That’s the level we demand internally and the reality our customers can count on.